---
title: "CBIO.US (CBIO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CBIO.US/news.md"
symbol: "CBIO.US"
name: "CBIO.US"
parent: "https://longbridge.com/en/quote/CBIO.US.md"
datetime: "2026-03-08T05:42:14.494Z"
locales:
  - [en](https://longbridge.com/en/quote/CBIO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CBIO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CBIO.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CBIO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CBIO.US/news.md)


# CBIO.US (CBIO.US) — Related News

### [Crescent Biopharma (NASDAQ:CBIO) Upgraded to Hold at Wall Street Zen](https://longbridge.com/en/news/278205667.md)
*2026-03-07T08:19:49.000Z*
> Wall Street Zen upgraded Crescent Biopharma (NASDAQ:CBIO) from a "sell" to a "hold" rating. Analysts have varied opinion

### [Crescent Biopharma Announces Grants of Inducement Awards | CBIO Stock News](https://longbridge.com/en/news/278168402.md)
*2026-03-06T13:15:00.000Z*
> Crescent Biopharma, Inc. announced the grant of options to purchase 45,675 shares to two non-executive employees as part

### [HC Wainwright Issues Optimistic Estimate for CBIO Earnings](https://longbridge.com/en/news/277942052.md)
*2026-03-05T13:15:16.000Z*
> HC Wainwright has raised its Q1 2026 earnings per share estimate for Crescent Biopharma (NASDAQ:CBIO) from ($1.33) to ($

### [](https://longbridge.com/en/news/277228570.md)
*2026-02-27T16:32:09.000Z*
> Crinetics Pharmaceuticals shares are trading lower. The company reported Q4 financial results.

### [12 Health Care Stocks Moving In Thursday's Intraday Session](https://longbridge.com/en/news/276363149.md)
*2026-02-19T17:05:43.000Z*
> In Thursday's intraday session, Dermata Therapeutics (DRMA) saw a significant gain of 54.1%, reaching $1.97, while Talks

### [3 'Strong Buy' Stocks to Buy Now, 2/19/2026, According to Top Analysts](https://longbridge.com/en/news/276342366.md)
*2026-02-19T13:46:47.000Z*
> Top Wall Street Analysts have identified three stocks as 'Strong Buys': Chewy (CHWY), Crescent Biopharma (CBIO), and Per

### [BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts](https://longbridge.com/en/news/276253918.md)
*2026-02-18T17:00:27.000Z*
> Crescent Biopharma's shares rose 4% to $9.68 following the announcement of a global early-stage trial for its experiment

### [Crescent Biopharma Announces First Patient Dosed In Ascend Phase 1/2 Clinical Trial Of CR-001](https://longbridge.com/en/news/276237014.md)
*2026-02-18T13:57:43.000Z*
> Feb 18 (Reuters) - Crescent Biopharma Inc:* CRESCENT BIOPHARMA ANNOUNCES FIRST PATIENT DOSED IN ASCEND PHASE 1/2 CLINICA

### [Crescent Biopharma starts ASCEND trial dosing 1st patient with CR-001, bispecific antibody, for solid tumors incl NSCLC, GI, gynecological.](https://longbridge.com/en/news/276229489.md)
*2026-02-18T12:32:34.000Z*
> ASCEND will conduct a clinical trial to assess CR-001, a bispecific antibody targeting PD-1 and VEGF, in various solid t